Nowtransit Inc
BioScience Health Innovations, Inc. distributes clinically tested and affordably priced products to battle the onslaught of bacteria and viruses. The company markets Be On-Guard Mouth Spray and Nasal Spray; EZ Safer Surface Cleaner; Be On-Guard brain fog support; Active Daily Health Defence 365 for maximum strength brain support; NeuroPro Plus, a patent pending combination of pharmaceutical grade… Read more
Nowtransit Inc (NOTR) - Net Assets
Latest net assets as of March 2025: $1.26 Million USD
Based on the latest financial reports, Nowtransit Inc (NOTR) has net assets worth $1.26 Million USD as of March 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($1.39 Million) and total liabilities ($132.92K). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $1.26 Million |
| % of Total Assets | 90.47% |
| Annual Growth Rate | 193.91% |
| 5-Year Change | 6416.15% |
| 10-Year Change | N/A |
| Growth Volatility | 194.8 |
Nowtransit Inc - Net Assets Trend (2019–2024)
This chart illustrates how Nowtransit Inc's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Nowtransit Inc (2019–2024)
The table below shows the annual net assets of Nowtransit Inc from 2019 to 2024.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | $835.24K | +12455.62% |
| 2023-12-31 | $-6.76K | -146.97% |
| 2022-12-31 | $14.39K | +212.52% |
| 2021-12-31 | $-12.79K | -199.80% |
| 2020-12-31 | $12.82K | +237.32% |
| 2019-12-31 | $3.80K | -- |
Equity Component Analysis
This analysis shows how different components contribute to Nowtransit Inc's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 34018300.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Other Components | $1.18 Million | 140.84% |
| Total Equity | $835.24K | 100.00% |
Nowtransit Inc Competitors by Market Cap
The table below lists competitors of Nowtransit Inc ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Ningxia Younglight Chemicals Co Ltd
SHE:000635
|
$295.21 Million |
|
Artesian Resources Corporation
NASDAQ:ARTNA
|
$295.24 Million |
|
Sinolong New Materials Co., Ltd.
SHE:301565
|
$295.26 Million |
|
China Reform Culture Holdings Co Ltd
SHG:600636
|
$295.30 Million |
|
FastPartner AB Series D
ST:FPAR-D
|
$295.16 Million |
|
GMR Power and Urban Infra Limited
NSE:GMRP&UI
|
$295.15 Million |
|
ENDUR ASA NK 050
F:4ZT0
|
$295.15 Million |
|
AGARWALEYE
NSE:AGARWALEYE
|
$295.11 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Nowtransit Inc's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from -6,760 to 835,240, a change of 842,000.
- Net income of 87,000 contributed positively to equity growth.
- New share issuances of 755,000 increased equity.
- Other comprehensive income increased equity by 14.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $87.00K | +10.42% |
| Share Issuances | $755.00K | +90.39% |
| Other Comprehensive Income | $14.00 | +0.0% |
| Other Changes | $-14.00 | -0.0% |
| Total Change | $- | % |
Book Value vs Market Value Analysis
This analysis compares Nowtransit Inc's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 683.53x
- The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
- The price-to-book ratio has decreased from 37368.16x to 683.53x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2019-12-31 | $0.00 | $13.00 | x |
| 2020-12-31 | $0.00 | $13.00 | x |
| 2021-12-31 | $0.00 | $13.00 | x |
| 2022-12-31 | $0.00 | $13.00 | x |
| 2023-12-31 | $0.00 | $13.00 | x |
| 2024-12-31 | $0.02 | $13.00 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Nowtransit Inc utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 10.42%
- The company shows good efficiency in utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 4.72%
- • Asset Turnover: 2.11x
- • Equity Multiplier: 1.05x
- Recent ROE (10.42%) is above the historical average (-102.41%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2019 | -47.37% | 0.00% | 0.00x | 1.00x | $-1.09K |
| 2020 | -59.93% | 0.00% | 0.00x | 1.61x | $-8.96K |
| 2021 | 0.00% | 0.00% | 0.00x | 0.00x | $-24.33K |
| 2022 | -517.58% | -107.43% | 4.27x | 1.13x | $-75.93K |
| 2023 | 0.00% | -42.09% | 6.40x | 0.00x | $-250.82K |
| 2024 | 10.42% | 4.72% | 2.11x | 1.05x | $3.48K |
Industry Comparison
This section compares Nowtransit Inc's net assets metrics with peer companies in the Pharmaceutical Retailers industry.
Industry Context
- Industry: Pharmaceutical Retailers
- Average net assets among peers: $239,198,060
- Average return on equity (ROE) among peers: -6.39%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Nowtransit Inc (NOTR) | $1.26 Million | -47.37% | 0.11x | $295.18 Million |
| Alibaba Health Information Technology Limited (ALBBY) | $1.12 Billion | -18.54% | 0.50x | $12.50 Billion |
| Allstar Health Brands Inc (ALST) | $-9.92 Million | 0.00% | 0.00x | $3.83 |
| Bimi International Medical Inc (BIMI) | $-409.66K | 0.00% | 0.00x | $296.83 |
| Blum Holdings Inc (BLMH) | $-4.74 Million | 0.00% | 0.00x | $8.97 Million |
| China Jo-Jo Drugstores Inc (CJJD) | $26.66 Million | -21.17% | 1.52x | $5.94 Million |
| Clicks Group Ltd (CLCGY) | $1.13 Billion | 41.98% | 2.72x | $4.80 Billion |
| China BCT Pharmacy Group Inc (CNBI) | $134.27 Million | 15.68% | 0.82x | $0.96 |
| Dalrada Financial Corp (DFCO) | $4.40 Million | -81.82% | 0.55x | $1.57 Million |
| Health Advance Inc (HADV) | $-105.34K | 0.00% | 0.00x | $25.40K |
| Healthwarehouse.Com (HEWA) | $-3.10 Million | 0.00% | 0.00x | $720.96 |